VYNDAQEL
VYNDAQEL
Approved
DIN Number
02495732
Drug Class
Human
Market Date
Apr 7, 2020
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02495732
AIG Number0162031001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07XX08 TAFAMIDIS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification24:04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
TAFAMIDIS MEGLUMINEActive
Strength: 20 MG
Monograph: TAFAMIDIS MEGLUMINE